Clinical Trial Detail

NCT ID NCT02382406
Title Carboplatin/Nab-Paclitaxel and MK-3475 in NSCLC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Jyoti Patel
Indications

non-small cell lung carcinoma

Therapies

Pembrolizumab

Carboplatin + nab-paclitaxel

Age Groups: adult

Additional content available in CKB BOOST